An implantable vagus nerve stimulation device yielded an ACR20 response rate of more than 52% at 12 months in patients with rheumatoid arthritis, according to findings published in Nature Medicine.

Correspondence to Dr Thomas Bandholm, Dept of Clinical Research, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre DK-2650, Denmark; thomas.quaade.bandholm{at}regionh.dk The REPORT guide ...

Feb. 6, 2026 Inspired by the shape-shifting skin of octopuses, Penn State researchers developed a smart hydrogel that can change appearance, texture, and shape on command. The material is programmed ...

Gain the skills, dexterity and confidence to propel your career into senior management. Whether the goal is to create a standalone solution or fashion part of a complex talent development initiative, ...